XML 49 R31.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Vaprisol, Omeclamox-Pak, Ethyol, and Methotrexate (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2016
Business Combinations [Abstract] |
Schedule of fair value assets and liabilities assumed in acquisition | The following table summarizes the allocation of the fair value of the assets acquired and liabilities assumed as of the acquisition date for Vaprisol:
Intellectual property intangible assets | $ | 2,990,000 |
Inventories | 1,410,000 |
Acquired contingent liabilities | (400,000 | )
Contingent consideration obligation | (2,000,000 | )
Total net assets acquired | $ | 2,000,000 |

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1486-128463 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463 + Details
Name: | us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration